Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04464668 · ClinicalTrials.gov registry record
Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health
A clinical trial of Colorectal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT04464668: Active study of Colorectal Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT04464668 is a study of Colorectal Cancer that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 49 participants, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04464668, a study of Colorectal Cancer, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to assess the impact of the CARES-REACH intervention on colorectal cancer screening rates.
Primary Outcome
Percentage of patients who complete initial Fecal Immunochemical Test (FIT)
Conditions Studied
Interventions
- BEHAVIORAL Provider Tools
- BEHAVIORAL Provider surveys
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2020-06-25 |
| Est. Completion | 2027-12 |
What the registry record for NCT04464668 still lists
NCT04464668 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,545-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Provider Tools is the first listed.
NCT04464668 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04464668 about?
NCT04464668 is a clinical study titled "Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health". This study is to assess the impact of the CARES-REACH intervention on colorectal cancer screening rates.
What is the current status of trial NCT04464668?
This trial is currently active not recruiting. The enrollment target is 49 participants. The study started on 2020-06-25. Estimated completion is 2027-12.
What conditions does trial NCT04464668 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT04464668?
The interventions under investigation include: Provider Tools (BEHAVIORAL), Provider surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT04464668?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04464668 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04464668's enrollment target sits among peer trials
49 275th of 381 higher than 106 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI